News

Newsmogrifydigital2021-11-02T09:15:40+00:00

FEATURED

CONTENT

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Tom Graney has been appointed to our Board of Directors as Non-Executive Director, Audit Chair and Capital Markets Advisor.

Tom has over 25 years’ of diverse and rich experience in biopharma that spans corporate development, commercial strategy, portfolio management, and value creation. He joins senior biopharma industry executives, Dr. Jane Osbourn OBE (Chair) and Dr. Lorenz Mayr, as an independent member of the Board of Directors.

Latest

NEWS

Mogrify appoints Profs. Christine Mummery, Graziella Pellegrini and Giulio Cossu to Scientific Advisory Board

Mark Cavanagh2022-05-09T10:42:31+00:002nd November 2020|

Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

Mark Cavanagh2022-05-09T10:42:45+00:009th October 2020|

Mogrify wins Life Science Innovation Award and Prof. Julian Gough named Academic Entrepreneur of the Year at Business Weekly Awards 2020

Mark Cavanagh2022-05-09T10:42:56+00:0018th September 2020|

Mogrify adds Dr. Lorenz Mayr to Board of Directors and Scientific Advisory Board

Betty Hou2022-05-09T10:43:02+00:0022nd July 2020|

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Mark Cavanagh2022-05-09T10:43:45+00:0021st April 2020|

Mogrify awarded $1.1M additional funding from SBRI Healthcare

Mark Cavanagh2022-05-09T10:43:51+00:0028th January 2020|

Load More Posts

Latest

Resources

VIEW ALL RESOURCES

VIEW ALL MEDIA FEATURES

VIEW ALL EVENTS

Follow Us On

Social Media